Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Active Surveillance of Asymptomatic, Presymptomatic, and Oligosymptomatic SARS-CoV-2-Infected Individuals in Communities Inhabiting Closed or Semi-closed Institutions.
Ambrosis N, Martin Aispuro P, Belhart K, Bottero D, Crisp RL, Dansey MV, Gabrielli M, Filevich O, Genoud V, Giordano A, Lin MC, Lodeiro A, Marceca F, Pregi N, Lenicov FR, Rocha-Viegas L, Rudi E, Solovey G, Zurita E, Pecci A, Etchenique R, Hozbor D. Ambrosis N, et al. Among authors: crisp rl. Front Med (Lausanne). 2021 Feb 4;8:640688. doi: 10.3389/fmed.2021.640688. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33614689 Free PMC article.
Myelodysplastic syndromes in Latin America: state of the art.
Crisp R, Grille S, Belli C, Diaz L, Undurraga S, Navarro J, Vidal G, Gusmao B, Reyes J, Huaman F, Magalhaes S, Barroso F, Ovilla R, Flores G, Choque JA, Di Stefano M, Salinas V, Iastrebner M; Latin-American Group for Myelodysplastic Syndromes GLAM. Crisp R, et al. Blood Adv. 2018 Nov 30;2(Suppl 1):60-62. doi: 10.1182/bloodadvances.2018GS110862. Blood Adv. 2018. PMID: 30504205 Free PMC article. No abstract available.
Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin-American cohort of 212 patients.
Lazzarino C, Arbelbide J, Schuster S, Crisp R, González J, Tavares R, Perusini MA, Di Stefano M, Pintos N, Espinosa D, Pimentel M, Rosenhain M, Serrano JC, Enrico A, Iastrebner M, Belli CB. Lazzarino C, et al. Am J Hematol. 2020 Dec;95(12):E323-E326. doi: 10.1002/ajh.25987. Epub 2020 Oct 1. Am J Hematol. 2020. PMID: 32864747 Free article. No abstract available.
A prospective study to assess the predictive value for hereditary spherocytosis using five laboratory tests (cryohemolysis test, eosin-5'-maleimide flow cytometry, osmotic fragility test, autohemolysis test, and SDS-PAGE) on 50 hereditary spherocytosis families in Argentina.
Crisp RL, Solari L, Vota D, García E, Miguez G, Chamorro ME, Schvartzman GA, Alfonso G, Gammella D, Caldarola S, Riccheri C, Vittori D, Venegas B, Nesse A, Donato H. Crisp RL, et al. Ann Hematol. 2011 Jun;90(6):625-34. doi: 10.1007/s00277-010-1112-0. Epub 2010 Nov 16. Ann Hematol. 2011. PMID: 21080168
Flow cytometry "Ogata score" for the diagnosis of myelodysplastic syndromes in a real-life setting. A Latin American experience.
Grille Montauban S, Hernandez-Perez CR, Velloso EDRP, Novoa V, Lorand-Metze I, Gonzalez J, Solari L, Cismondi V, Serrano JC, Burgnini A, Rabelo-Carrasco LJ, Bacal N, Trias N, Guevara R, Rico Vido J, Crisp R, Enrico A, Boada M, Pereira Cunha FG, Fanessi V, Venegas MB, Issouribehere D, Novoa A, Lens D. Grille Montauban S, et al. Int J Lab Hematol. 2019 Aug;41(4):536-541. doi: 10.1111/ijlh.13047. Epub 2019 May 8. Int J Lab Hematol. 2019. PMID: 31066993 Clinical Trial.
14 results